Healthcare Fraud Analytics Market size is evaluated at USD 3.1 billion in 2024 and is anticipated to cross USD 42.1 billion by the end of 2037, expanding at more than 24.3% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of healthcare fraud analytics is estimated at USD 3.8 billion.
The crucial growth drivers that fuel the growth of the market are budding health expenditures that open avenues for fraudulent claims and thus make it imperative to adopt advanced analytics. Also, a wide acceptance of data analytics and AI in healthcare facilitates detecting and preventing fraudulent claims. Furthermore, regulatory pressures and compliance mandates fuel market growth as healthcare organizations strive to meet the standards. With the rising incidence of healthcare fraud associated with identity theft, billing errors, and the manipulation of a patient's medical records, the need for proactive detection rises and drives growth. Moreover, advances in machine learning and predictive modeling and the shift from pay-and-chase to enable real-time prevention of loss in financial fraud assist the market to be opportunistic.
Another significant reason for the market propels owing the growing demand due to IoT and cloud computing, real-time analytics, and visualization, the need for risk management and compliance solutions is growing, as value-based care and payment integrity. Thus, all these factors come together and form a compelling business case for healthcare fraud analytics and drive investments and innovation in the market. In August 2024, Medibuddy introduced Sherlock, a cutting-edge AI-enabled fraud detection system that allows for the real-time detection of medical reimbursements incorporated with artificial intelligence, machine learning, and data analytics.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
24.3% |
|
Base Year Market Size (2024) |
USD 3.1 billion |
|
Forecast Year Market Size (2037) |
USD 42.1 billion |
|
Regional Scope |
|
Solution Type (Descriptive, Prescriptive, Predictive)
Descriptive segment is predicted to dominate over 60% healthcare fraud analytics market share by 2037, primarily for its ability to provide an all-encompassing view of data history and trends, which helps to observe patterns in fraud behavior. Such analysis uses a vast amount of healthcare data, claims, billing records, and patient information to optimize standard operating benchmarks. Growth drivers for descriptive analytics include increased data volumes in healthcare, advanced fraudulent schemes, and the need for healthcare organizations to leverage better compliance and risk management.
In addition, improving technology in data processing and advanced algorithms associated with machine learning helps in making detailed analysis easier and ensures easy identification of anomalies. Descriptive analytics can help healthcare service providers not only detect past cases of fraud but also design predictive models to predict risks in the future, thus making their strategies against fraud more robust and consequently upholding the integrity of healthcare services.
Deployment Mode (On-premises, Cloud-based)
By 2037, on-premises segment is expected to account for around 59.2% healthcare fraud analytics market share due to increased reliability about data security and confidentiality provided by on-premises solutions. Also, organizations tend to favor control over data infrastructure to comply with even the most rigid regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) in the U.S., to guard patient data against unauthorized access. The most conducive argument for on-premises deployment lies in greater ease of customization and integration with existing systems giving healthcare providers control over analytics solutions and tailoring them to unique operational workflows and requirements.
Additionally, on-premises solutions can provide better performance and faster processing since they depend on local servers and resources, which may be very valuable to an organization handling large volumes of data. All these factors collectively make on-premises lead the market in healthcare fraud analytics and promote security, customization, performance, and cost-effectiveness for fraud detection.
Application (Insurance Claims Review, Pharmacy Billing Issue, Payment Integrity)
Insurance claims review segment in the healthcare fraud analytics market is anticipated to grow at over 24.3% CAGR between 2025 and 2037 driven by some compelling reasons in maintaining the integrity of healthcare financing. The volume of insurance claims processed necessitates the development of an effective review mechanism to identify and mitigate fraudulent activities. As the cost of health care continues to escalate, the increased emphasis is ensuring claims are properly vetted to avoid losses from fraudulent billing practices. Regulatory pressures and compliance need also fuel insurance companies to institute comprehensive claims review programs to ensure standards and avoid possible penalties.
Furthermore, advanced analytics tools have enhanced the accuracy and sophistication of claims assessment. Moreover, incorporating machine learning and AI in the processes of reviewing claims informs the identification of fraud indicators through patterns and anomalies to improve detection for patient safety and quality. Thus, the insurance claims review segment is expected to propel while ensuring compliance and enhancing overall operational efficiency.
Our in-depth analysis of the market includes the following segments:
|
Solution Type |
|
|
End user |
|
|
Deployment Mode |
|
|
Application |
|
North America Market Statistics
North America in healthcare fraud analytics market is projected to dominate around 35.6% revenue share by the end of 2037 owing to its advanced healthcare infrastructure, which includes a vast provider network, health insurance companies, and regulatory authorities. Such a huge infrastructure requires effective tools to detect and prevent fraud so that avoidable financial losses are not incurred as a result of fraudulent activities. Healthcare institutions are implementing advanced analytics solutions to meet regulatory compliance in the form of HIPAA, ACA, and other related laws. Moreover, since fraud schemes are on the rise, healthcare organizations require more innovative forms of analytics tools that exploit artificial intelligence and machine learning to better enhance detection capabilities.
Investments within North America, both in the public and private sectors in technology and data analytics have created a space where effective fraud analytics solutions can flourish. Also, the growing awareness of the financial as well as reputational impacts by various groups of stakeholders on the different dimensions of healthcare fraud has led to a proactive approach to embrace holistic fraud analytics strategies. Thus, North America is at the apex of the healthcare fraud analytics market.
In the U.S., the health care fraud unit within the criminal division’s fraud section had been created where a dedicated data analytics team monitors billing trends, identifies aberrant providers, and helps our prosecutors spot emerging schemes and stop them.
Asia Pacific Market Analysis
The Asia Pacific is growing at a healthy pace in the healthcare fraud analytics market, influenced by a couple of significant factors attributable to witnessing an enormous increase in healthcare expenses that is being driven by rising populations, urbanization, and an ever-growing middle class. This crucial incurred expenditure has subsequently catalyzed growth in healthcare services and insurance coverage, thus increasing demand for efficient mechanisms to detect and prevent fraud. Also, the increased awareness by government and private organizations on healthcare fraud and its implications has facilitated an increased investment in analytics solutions to combat fraudulent activities.
Moreover, recent regulatory frameworks implemented on healthcare transparency and accountability have further increased the pressure of demand on sophisticated tools for fraud analytics. Advances in digital health technologies, such as telemedicine and electronic health records, also started to generate immense data that must be used on advanced analytics to identify fraud risks and mitigation in general. Additionally, the fast adoption of artificial intelligence and machine learning technologies in the region further boosts the capabilities of fraud detection systems to higher efficiency and effectiveness.
In July 2023, A penalty amount of USD 1.14 million was recovered while 210 hospitals were de-impanelled based on information of fraud obtained through artificial intelligence and machine learning-based anti-fraud initiatives.
The healthcare fraud analytics market covers a diversified range of market players striving to develop innovative solutions for combating the number of frauds in the industry. Owing to distinctive capabilities and expertise companies are serving as a forefront in enhancing efforts toward fraud detection and measures for prevention. Key market players leveraging cutting-edge technologies are:
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?